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Abstract 
Purpose: It is of clinical interest to study liver deformation during breathing by applying 
deformable image registration (DIR) on respiratory correlated four-dimensional (4D) 
images. This study aims to evaluate and compare the accuracy of DIR-derived liver 
deformation based on 4D computed tomography (CT) and 4D magnetic resonance 
imaging (MRI).  
Methods: 4D CT, 4D MRI and cine magnetic resonance (MR) images of liver region were 
acquired from 5 patients with liver cancer under an IRB-approved protocol. ROIs 
containing tumors in each patient were tracked multiple times (3~5) in cine MR images. 
The trajectories from tracking, covering several breathing cycles, were converted to 
trajectories in one breathing cycle through phase sorting. The average phase sorted 
trajectories for each patient were used as reference trajectories after manual verification. 
Deformation vector fields (DVFs) from 4D CT and 4D MRI were generated via DIR 
implemented in Velocity AI. To enable comparison between DVFs and reference tumor 
trajectories, deformation vectors from each frame were linked together, forming DVF-
based trajectories at each voxel. All DVF-based trajectories within each ROI were 
averaged to represent tumor motion. The single-phase difference, the trajectory 
difference and the correlation coefficient between each pair of DVF-based trajectory and 
reference trajectory were calculated. Wilcoxon signed-rank tests were conducted to 
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determine whether there was significant difference between the single-phase 
differences, the trajectory differences and the correlation coefficients for 4D CT and 4D 
MRI.  
Results: In the superior-inferior (SI) direction, 4D CT trajectories exhibit smaller 
trajectory differences (traj. diff.) in millimeters on average (traj. diff. (mm)= 
2.09±0.75mm) but larger trajectory differences in number of voxels (traj. diff. (voxels)= 
0.87±0.29) and smaller correlation coefficients (c. c. = 0.89±0.09) than 4D MRI trajectories 
(traj. diff. (mm)= 2.23±1.46mm, traj. diff. (voxels)= 0.45±0.29, c. c. = 0.93±0.06) whereas 4D 
MRI (traj. diff. = 1.09±1.23mm, traj. diff. (voxels)= 0.60±0.65, c. c. = 0.59±0.30) surpasses 
4D CT (traj. diff. = 1.30±1.36mm, traj. diff. (voxels)= 1.02±1.07, c. c. = 0.15±0.64) in every 
metric in the right-left (RL) direction. In the anterior-posterior (AP) direction, 4D MRI 
trajectories have smaller trajectory differences in millimeters (traj. diff. (mm) = 
1.11±0.70mm) and smaller trajectory differences in voxels (traj. diff. (voxels) = 0.61±0.36) 
but slightly smaller correlation coefficients (c. c. = 0.72±0.26) than 4D CT trajectories (traj. 
diff. (mm) = 1.47±0.63mm, traj. diff. (voxels) = 1.15±0.50, c. c. = 0.77±0.26). A trend that 
the trajectory differences in voxels for 4D MRI are smaller than those for 4D CT in every 
direction has been observed, though the results of Wilcoxon signed-rank tests do not 
support there is any significant difference between the accuracy of DVFs from 4D CT 
and 4D MRI.  
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Conclusion: We have implemented a novel approach for evaluating accuracy of DVFs 
based on 4D imaging for studying liver deformation. Current results indicate that the 
accuracy of DVFs from 4D CT and 4D MRI are comparable. Trends suggesting that the 
DVF from 4D MRI can be potentially more accurate than the DVF from 4D CT have been 
observed. Further study on more patients is warranted to determine whether there is 
significant difference between 4D CT and 4D MRI and to what degree the accuracy of 
the DVF from 4D MRI can be improved.  
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1. Introduction  
1.1 Respiratory Motion – A Challenge in External Beam 
Radiation Therapy 
External beam radiation therapy (EBRT) utilizes ionizing radiation beams, most 
commonly photon and electron beams, delivered from outside the patient body to kill 
cancer cells. Tumor control probability (TCP), a metric for the efficacy of radiation 
therapy, can be calculated using the following equation,  
   ∑ 	
  
where N=initial number of cancer cells, f=number of fractions, di=dose to cancer cell i, α 
and β are parameters in the linear quadratic model for radiation effects1-4. Ionizing 
radiation is toxic to not only cancer cells but also normal cells. Concerns about excessive 
cell killing to normal cells prevent physicians from prescribing higher dose to the tumor, 
especially when organs-at-risk (OARs) are near or overlapping the target. Normal tissue 
complication probability (NTCP) serves as a metric for toxicity of radiation to normal 
tissues, which is calculated using the following equation, 
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TD50=tolerance dose for 50% probability of injury, di=dose to cancer cell i or region i, 
Vi=volume at dose di, m and n are tissue specific parameters in Lyman-Kutcher-Burman 
model1, 5, 6.  
As implied in the above equations, dose distribution is crucial for evaluation of 
the outcomes of radiation therapy. However, it is much more complicated to calculate 
the accumulated dose for targets and normal tissues that keep moving during beam 
delivery than for static ones. The main barrier is the lack of an accurate method to map 
dose distribution in a specific phase to the reference phase. Theoretically, if motion 
trajectories of each region that is sufficiently small are known, dose warping7-13 can be 
accomplished. Although the breath-hold approach has been used to circumvent the 
problem by freezing the motion of moving targets and normal tissues, a large number of 
patients still have to receive free-breathing and phase-gating radiation therapy, during 
which targets and normal tissues keep moving. Therefore, it is of clinical interest to 
obtain quantitative motion information at different phases for accurate calculation of 
accumulated dose distribution.  
1.2 Overview of Four-dimensional (4D) Computed Tomography 
(CT), 4D Magnetic Resonance Imaging (MRI), and Cine MRI 
Various techniques have been developed to image the respiratory motion of 
tumors and normal tissues by adding a time dimension to or improving the temporal 
resolution of existing imaging modalities. Images obtained via these techniques contain 
motion information that, if properly extracted, can be used for dose warping.  
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4D CT has been widely used for evaluation of respiratory motion in clinical 
radiation therapy14-19. 4D CT works in cine mode, meaning that, instead of one image at 
each slice, multiple images will be acquired at each slice location for a minimal duration 
of a respiratory cycle. Each image will be subsequently assigned to a frame according to 
the phase in a respiratory cycle, at which it is acquired. Images from all slices in the 
same frame form a volume and anatomic changes can be seen between different frames. 
A unique advantage of 4D CT is that it provides information of electron density, which 
is necessary for dose calculation.  
In contrast to the well-accepted and widely-used 4D CT technique, 4D MRI20-23 is 
relatively new and not yet a routine procedure for motion evaluation. However, the role 
of 4D MRI in 4D radiation therapy is expected to be promising because it provides 
motion information and meanwhile retains the advantages of conventional MRI 
including high soft-tissue contrast and absence of radiation hazard. High soft-tissue 
contrast may be beneficial especially in the abdominal region where 4D CT images tend 
to exhibit a poor contrast. Absence of radiation hazard allows prolonged acquisition, 
which may lead to better image quality.  
Currently, 4D MRI can be implemented in either cine mode or sequential mode. 
Cine mode acquisition is similar to the acquisition method used in 4D CT. Images at a 
slice location are acquired repeatedly for no shorter than a respiratory cycle and are 
subsequently sorted into different frames based on their phases. Sequential mode is also 
 commonly used, especially for those sequences that do not support cine mode 
acquisition. In sequential acquisition, images are acquired from the first slice location to 
the last and the acquisition will be repeated from the first slice location again
sufficient images have been collected for every slice location
into corresponding frames 
associated respiratory curve. Sequential mode typically takes longer than 
implying that redundant information is acquired. This redundancy makes sequential 
mode more robust to irregular breathing. R
breathing will render the 4D MR
acquired in cine mode but is not likely to cause the same consequence if the raw images 
are acquired in sequential mode. 
Figure 1: Coronal images of 4D 
Cine magnetic resonance (
same location. The acquisition of cine MR images
4 
. The images will be sorted 
by matching the time stamps of the images with
emoval of images acquired during irregular 
I reconstruction impossible if the raw images are 
 
CT (left) and 4D MRI (right) at the same 
location.  
MR) images are acquired by repeatedly imaging at the 
 is actually the basic procedure 
 until 
 the 
cine mode, 
 
in cine 
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mode 4D MRI acquisition but can extend to multiple respiratory cycles. The frame rate 
of cine MRI typically ranges from 3 to 7 frames per second. Because phase sorting is not 
involved in cine MRI, cine MR images are free from artifacts caused by irregular 
breathing. Cine MR images that cutting through the center of target are commonly taken 
in the sagittal, coronal, and axial views for motion evaluation.  
1.3 The Displacement Vector Field (DVF) 
The DVF, representing a voxel-based correlation between two volumes or 
frames, is introduced to describe deformation between the primary and the secondary 
volumes. As of now, the DVF can be generated via a variety of commercially available 
software and open-source deformable image registration (DIR) programs. Typically, 
displacement vectors are defined at each voxel in the primary volume and end at the 
most probable positions that voxels in the primary volume correspond to in the 
secondary volume. Since deformation in anatomy observed in 4D images essentially 
results from the respiratory motion, in theory, the DVF represents how each voxel in the 
primary volume move from the phase of the primary volume to the phase of the 
secondary volume. Therefore, the DVF can be used as quantitative motion information 
for accumulated dose calculation.  
Because images are based on voxels with fixed physical size whereas tissues may 
change in shape, the anatomy represented in a single voxel in a phase can expand to 
several voxels in another phase and tissue occupying multiple voxels in a phase can 
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shrink to only one voxel in another phase. Due to this characteristic, it is noteworthy that 
the correlation described by the DVF is not voxel-to-voxel or readily invertible.  
The DVF from 4D CT images has been extensively investigated24-28. With the 
availability of 4D MRI techniques, it is warranted to study the DVF from 4D MRI, 
especially in the abdominal region, considering the improved soft-tissue contrast in 4D 
MRI images.  
1.4 Current Approaches to DVF Evaluation 
Accuracy of the DVF should be scrutinized before conclusions are made from 
calculation based on the DVF. A variety of techniques29-37, which can be categorized into 
two approaches, phantom and human subject, have been proposed to evaluate the 
accuracy of DVFs.  
It is common to use digital and physical phantoms for DVF evaluation. Easy 
access to the ground truth, or the actual displacements, and the controllability of motion 
are beneficial. The phantoms can also tolerate virtually any amount of radiation dose 
without raising concerns about overdose, enabling high quality images to be acquired 
for DVF generation. Limitations of phantoms are as obvious. Most phantoms, especially 
physical phantoms, are not likely to contain as detailed anatomy as in human body. 
Tissues are often assumed to be homogeneous, lacking internal variation in density, 
composition, elasticity, etc. This homogeneity naturally leads to motion homogeneity, 
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meaning that an organ tends to move as a whole as a rigid body, which is not the case in 
the human body.  
Patient or volunteer study is preferred for comprehensive evaluation. Implanted 
markers, anatomical landmarks, and contrast agents such as hyperpolarized gas have 
been used to provide the ground truth. Displacements derived from DIR algorithms are 
compared with displacements obtained from tracking or measurement in images. 
Limitations still present in these approaches. Implanting markers is invasive and may 
not be justifiable for health volunteers and many patients. Land markers may not be 
suitable for images with low quality such as low contrast, high noise. For instance, the 
liver in 4D CT images tends to be homogeneous without many landmarks. The major 
limitation of the hyperpolarized method is its limited application to the lungs.  
1.5 Aims of This Study 
This study aims at evaluating the accuracy of liver DVFs from 4D CT and 4D 
MRI. 4D CT has been long developed for assessing internal body motion in the lung 
region. It was not applied in liver region until recently38, 39. 4D MRI is expected to 
provide better contrast and motion information in the liver region. In 4D radiation 
therapy, the DVF has been proposed to be used for dose warping between different 
frames for calculation of accumulated dose. This potential application, however, is not 
yet widely accepted because of the difficulty in verifying DVFs from clinical 4D CT and 
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4D MRI images due to lack of ground truth. In this study, cine MRI images are used as 
reference for evaluation of DVFs from 4D CT and 4D MRI in the liver region. 
The underlying principle that enables cine MR images to serve as reference is 
that they contain respiratory motion information, although only available for voxels in a 
few individual slices, typically three orthogonal slices cutting through the center of 
tumor. In addition, because ideally the deformation information obtained from DIR 
should reflect the actual respiratory motion information, the motion information in cine 
MR images can be utilized to evaluate the accuracy of DVFs. In practice, both DVFs and 
cine MR images need to be converted to a common form before evaluation, which is 10-
phase single-cycle tumor trajectory in this study.  
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2. Materials and Methods 
2.1 Patient Selection 
Since this study aims at evaluating the accuracy of liver DVFs from 4D CT and 
4D MRI using cine MR images as reference, an eligible patient should have 4D CT, 4D 
MRI, and cine MR images of the liver. As of now, 4D MRI is not yet a standard imaging 
procedure for patients with liver cancer. The 4D MR images used in this study are from 
patients accrued in an IRB-approved protocol for a 4D MRI study.  
Because tumor motion trajectories obtained directly from tracking in cine MR 
images would be used as reference trajectories, tumors in cine MR images had to be of 
good contrast for the tracking algorithm to work. Among all patients with complete 
image data, those with visually identifiable tumors in cine MR images were tested for 
tracking regardless the type and the size of tumor. Patients with reasonable trajectories 
from tracking in cine images were finally enrolled in this study. Reasonability of 
trajectories from tracking in cine images was examined case by case.  Specific reasons for 
exclusion of certain patients will be explained in the Results section.  
Ideally, tumor visibility in 4D CT and 4D MR images should also be counted as 
one of the criteria for eligibility check. However, it is not uncommon that, even for the 
same patient, images of different modalities do not exhibit consistently high image 
quality. Considering the already small size of the pool from which patients were chosen 
from and the existence of alternative approach to localize tumors of poor contrast in 4D 
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CT and 4D MR images, tumor visibility in 4D MR and 4D cine was not checked for 
patient inclusion and exclusion.  
2.2 Image Acquisition 
4D CT images used in this study were acquired in cine mode, using a phase 
gating protocol at 120kVp, on a GE Medical Systems LightSpeed RT® CT scanner and a 
Siemens Biograph™ 40 PET/CT scanner. The 4D CT images were generated using phase 
sorting by matching the time stamp of each image with the synchronized respiratory 
curve recorded by a Varian® Real-time Position Management™ (RPM) system.  
4D MR images used in this study were acquired in cine mode, using the FIESTA 
sequence on a GE Medical Systems Signa HDxt 1.5T MR scanner. FIESTA, which stands 
for Fast Imaging Employing Steady-state Acquisition is a GE developed sequence that 
uses the T2 steady state contrast mechanism to provide high signal-to-noise ratio (SNR) 
images with strong signal from fluid tissues while suppressing background tissue for 
contrast and anatomic detail of small structures. In addition, the ultra-short TR and TE 
enable extremely short acquisition times, which satisfy the requirement for temporal 
resolution of 4D MRI. The body area, defined as the number of voxels inside the skin, 
was used as the internal surrogate of respiration and the phase of each image was 
determined by the body area in the image.  
Cine MR images were acquired using the FIESTA sequence on a GE Medical 
Systems Signa HDxt 1.5T MR scanner. Detailed parameters are listed in Table.2.  
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Table 1: Voxel size of 4D CT and 4D MR images used in this study.  
Patient Modality In-plane Resolution (mm) Slice Thickness (mm) 
1 
4D CT 1.270 2.500 
4D MRI 1.875 5.000 
2 
4D CT 1.270 2.500 
4D MRI 1.406 5.000 
3 
4D CT 1.367 2.000 
4D MRI 1.875 5.000 
4 
4D CT 1.270 2.500 
4D MRI 1.875 5.000 
5 
4D CT 1.270 2.500 
4D MRI 1.875 5.000 
 
Table 2: Parameters of cine MR images used in this study.  
Patient Direction 
In-plane 
Resolution (mm) 
Slice Thickness 
(mm) 
Frame Rate 
(frames/second) 
No. of 
Frames 
1 
Coronal 1.875 5.000 2.53 180 
Sagittal 1.875 5.000 4.07 180 
2 
Coronal 1.406 5.000 2.30 180 
Sagittal 1.875 5.000 4.07 180 
3 
Coronal 1.875 5.000 2.84 100 
Sagittal 1.875 5.000 2.84 100 
4 
Coronal 1.875 5.000 2.84 100 
Sagittal 1.875 5.000 3.47 100 
5 
Coronal 1.875 5.000 2.44 180 
Sagittal 1.875 5.000 3.03 180 
 
 Figure 2: The study design
tracking tumors in the cine MR images. DVF
2.3 Generation of Reference Tumor Trajectories from Tracking in 
Cine MR Images 
2.3.1 Software 
Tracking for tumor 
tracking graphical user interface 
algorithm. After manual selection of
determine the displacement of th
position in the reference (the first frame) 
maximized in the current frame
and phase sorting were developed
12 
. The reference trajectories were acquired by 
-based trajectories were generated from 
4D CT and 4D MRI DVFs. 
trajectories is implemented via an in-house developed 
(GUI) based on a cross-correlation image registration 
 a region of interest (ROI), the program
e ROI in each frame, which shifts the ROI
to the position where cross-correlation is 
. Programs for post-processing including 
.  
 
 will 
 from the 
peak detection 
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2.3.2 ROI selection 
Tumors in cine MR images were localized visually. Since the tracking algorithm 
relies on the characteristic difference in pixel intensity, the tumor region must have a 
decent contrast such that it can be distinguished from the surrounding tissues by the 
tracking algorithm. If tumor contrast is too low, the patient has to be excluded because, 
even if tumor position is determined with the aid of extra information, e.g. gross tumor 
volume (GTV) contours in the treatment planning system (TPS), such knowledge of 
tumor position still cannot be utilized by the tracking GUI. However, it is worth noting 
that quality of tracking results may not agree with image quality estimated visually. 
Therefore, it is warranted to perform tracking on cine MR images of an extensive 
number of patients, even those patients whose cine MR images do not appear to be 
promising visually, as long as the tumor can be seen in the cine MR images, and a 
patient should not be excluded until tracking results justify the exclusion.  
2.3.3 Tracking and Correction 
Cine MR images were first loaded into the tracking GUI and the first frame 
would be displayed in the interface. Next, a rectangular ROI would be drawn manually 
to include the tumor in the image. The ROI would be used as the template later during 
the tracking process. To obtain the optimal result, the ROI was drawn as small as 
possible provided the entire tumor was encompassed. The larger the ROI is, the more 
pixels that represent the surrounding tissues instead of the tumor will be included, 
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rendering the tracking result less likely to reflect the motion of tumor accurately. The 
GUI allows a polygon to be drawn after ROI selection. The polygon serves as a real-time 
indicator of where the template is shifted to.  
Tracking results may not maintain reliable throughout the entire course of 
tracking due to unfavorable structural characteristics and suboptimal image quality. The 
most undesirable and obvious effect of this imperfect tracking is discontinuities in 
displacement curves. For instance, the displacement of a ROI at a certain frame could be 
as high as more than 20mm to the superior whereas the displacements at adjacent 
frames were only approximately 8mm. If a discontinuous point was observed in the 
real-time tracking results and was accompanied by a sudden large change of the 
polygon’s position, the point would be classified as abnormal.  
If a displacement curve did not have any abnormal point, it would be accepted as 
a tumor trajectory from tracking in cine MR images. If a displacement curve did have 
abnormal points but did not have successive abnormal points of three or more, the curve 
will be corrected for acceptance. Otherwise, the curve would not be accepted and 
tracking would be repeated if necessary. The values of abnormal points were set to the 
interpolated values rounded to the nearest multiples of pixel size, e.g., 1.875mm, 
5.625mm, for images with an in-plane resolution of 1.875mm.    
 To minimize the unce
tumor localization, each tumo
from tracking in cine MR images 
Figure 3: Tracking GUI used for tumor trajectory tracking in cine MR images. 
The image in the left is the ROI in a coronal frame that is currently being processed 
with the polygon used for real
(red) and the 
2.3.4 Generation of Reference Tumor Trajectories from Tracking in 
Cine MR Images (Single
2.3.4.1 Peak Detection and Correction
A peak detection program
used to identify the peaks 
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r were tracked 3 to 5 times and average tumor
were used for following processing.  
-time shift indication. The plot in the right shows the SI 
RL (black) trajectories from tracking. 
-cycle Tumor Trajectories) via Phase S
 
 capable of ignoring temporally small fluctuation was 
and valleys of tumor trajectories from tracking
algorithm and 
 trajectories 
 
orting 
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rarely incorrectly identified peaks and valleys of average tumor trajectories from 
tracking in the SI direction but occasionally picked wrong points in the RL and the AP 
directions.  
Since tumor motion in all the three directions were correlated and the trajectories 
in the SI direction were the most reliable, peaks and valleys of the RL and the AP 
trajectories were checked against the peaks and valleys in the SI trajectories. Only those 
in the RL and the AP trajectories that had corresponding peaks or valleys in the SI 
direction were retained whereas the others were treated as intra-cycle fluctuation and 
deleted.  
2.3.4.2 Phase Sorting 
Cine MR images are typically acquired for multiple respiratory cycles and, thus, 
tumor trajectories from tracking last for multiple cycles as well. To enable comparison, 
multi-cycle tumor trajectories from tracking have to be converted into trajectories that 
last for only one respiratory cycle. This conversion was implemented by phase sorting, 
the same method used for 4D MRI reconstruction. The core step in phase sorting is 
binning. Each interval between two adjacent valleys were divided into 10 sub-intervals, 
or bins. Each frame was subsequently assigned to one of the ten bins according to its 
frame number. The magnitude of displacement for a bin was calculated by averaging the 
magnitudes of displacement in all the frames in the bin. The magnitude of displacement 
at frame 10, representing the EOI phase, was set to zero. By doing so, 10-phase tumor 
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motion trajectories lasting for a single respiratory cycle were generated and used as 
reference tumor trajectories.  
2.4 Generation of DVF-based Tumor Trajectories 
2.4.1 Software 
An in-house developed GUI was used for 4D MRI image reconstruction. Velocity 
AI was used to generate DVFs from 4D CT and 4D MRI. Programs for post-processing 
including DVF display and generation of DVF-based tumor trajectories were developed.  
2.4.2 Image Preparation  
4D CT images were directly imported into Velocity AI for DVF generation 
because 4D CT data had already been sorted into 10 phases when they were obtained 
from the CT scanner.  
4D MRI used in this study was acquired in cine mode. Reconstruction was 
needed to convert raw data into 4D MRI images. The respiratory peaks were first 
detected by using body area as surrogate. The body area was determined according to 
the following steps. First, draw an ROI that covers a segment of body surface in the first 
frame of raw 4D MR data and leave enough room in the upper and lower part of the 
ROI such that the surface will not go beyond the upper or lower boundaries. Second, set 
the values of pixels with a value greater than a certain threshold to 1 and the values of 
rest of the pixels to 0. The number of pixels with a value of 1 in the ROI is defined as the 
body area. Ideally, if the threshold is properly chosen, all the pixels inside the body 
 surface will be 1 and those outside will be 0.
free results. The peaks of body area curves may not be consistent with the peaks of 
respiratory curves. Therefore, a manual check wa
accurate.  
Figure 4: The rectangular region in the left figure is selected for body area 
calculation. The rectangle in the right figure is the region selected in the left figure. 
Voxels inside the body are set to white and voxels outside the body to b
of white voxels in the right figure is defined as the body area.
The raw data of 4D MRI images and the corrected peaks were input into the GUI 
and 4D MRI images were reconstructed using phase sor
discarded due to improper contrast. 
2.4.3 ROI selection  
All the tumors in 4D CT and 4D MR
using GTV contours in the 
images at the EOI phase. The sagittal, coronal, and axial planes that cut through the 
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image “zero” of the CT and MR images in the TPS were snipped and used to help 
determine the “zero” of 4D images by comparing 4D images slice-by-slice with the 
orthogonal planes. The distances from the “zero” to the most right, left, anterior, 
posterior, inferior, and superior slices that the GTV contour extended to were also 
acquired from the TPS. With prior knowledge of voxel sizes, the location of the most 
right, left, anterior, posterior, inferior, and superior slices that the GTV contour extended 
to in 4D images could be determined. In this study, the tumor region in 4D CT and 4D 
MR images was represented by the rectangular region encompassed by the six slices.  
A potential error in tumor localization lies in that the planning images in the TPS 
were breath-hold images whereas the 4D CT and 4D MR images in which the tumor was 
localized are EOI images. Since patients tend to be asked to take a deep breath and hold 
it during the breath-hold imaging, the diaphragm can be lower than in EOI phase. To 
correct this discrepancy, the distances from the center of the rectangular volume 
encompassed by the six slices to the diaphragm, the right side of the body, the posterior 
side of the body in the TPS were recorded and the rectangular tumor region in the EOI 
images was shifted to match the distances with those measured in the TPS, the rationale 
being that, since the tumor moves during respiration, it is more reasonable to define the 
tumor location with respect to the moving tissues such as diaphragm.  
 2.4.4 Generation of DVF
Figure 5: DVFs from 4D CT (
the EOE phase in the coronal view in the liver.
20 
s 
top) and 4D MRI (bottom) between the EOI and 
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DVFs used in this study were generated via Velocity AI. A set of 4D images 
consisting of 10 frames were imported into the Velocity database frame by frame. Each 
frame was renamed according to its frame number. For both 4D CT and 4D MR images, 
the end-of-inhalation (EOI) phase was defined as the 95%-5% phase (frame 1). In reality, 
however, the frame in which the diaphragm reaches its lowest position may not be 
exactly the frame 1 but could possibly range from frame 10 to frame 2. This discrepancy 
may come from possible phase shift between the tumor motion and external surrogate 
used in 4D CT and 4D MRI reconstruction. To facilitate comparison, the frame with the 
most inferior diaphragm was defined as the EOI phase, or reference frame, and used as 
primary volume for registration. All the other frames were defined as secondary 
volumes and each of them was registered with the reference frame.  
To eliminate ambiguity, displacement vectors generated from Velocity AI point 
from each voxel in the primary volume to the secondary volume. In other word, if the 
voxels in the primary volume move according to the DVF, the deformed volume will 
have maximum similarity with the secondary volume.   
For a set of 4D CT or 4D MRI images with 10 frames, 9 DVFs were generated 
between the reference frame and each of the remaining 9 frames. Deformable Multipass 
algorithm was used for 4D CT deformation and MR Corrected Deformable for 4D MRI 
deformation.  
 2.4.5 Generation of DVF
Figure 6: An illustration of 
based tumor trajectories. The color fades as the phase proceeds from the EOI to the 
EOE phase. The ascending part and the descending part overlap because of 
magnitude of displacement in the RL direction. 
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By connecting the endpoints of all the displacement vectors in temporal order, a 
motion trajectory were created for each voxel. All the motion trajectories in the ROI were 
subsequently averaged. To make the average trajectories comparable with tumor 
trajectories obtained from tracking in cine MR images, an addition data point with a 
value of zero was added to the end of each average trajectory to represent the position of 
the tumor in the reference frame. The 10-phase average trajectories were defined as 
DVF-based tumor trajectories.  
2.5 Evaluation of DVFs from 4D CT and 4D MRI 
This study aims at evaluating the accuracy of DVFs from 4D CT and 4D MRI 
using cine MR images as reference. Theoretically, under the assumption of regular 
breathing, the respiratory motion reconstructed from 4D images via deformation should 
agree with that from tracking in cine MR images. Therefore, the discrepancy between 4D 
DVF-based trajectories and cine MR trajectories can indicate DVFs from which modality 
are more accurate. Metrics used in this study include single-phase difference (ph. diff.), 
trajectory difference (traj. diff.), and correlation coefficient (c. c.), which are defined as 
follows.  
Suppose r1, r2 ... r10 are the displacements of the reference trajectory in a certain 
direction for a patient, and a1, a2 ... a10 are the displacements of a 4D CT DVF-based or 4D 
MRI DVF-based trajectory for the same patient.  
The ph. diff. at phase i is defined as 
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The traj. diff. is defined for each DVF-based trajectories as  
?><@. ):;;.  ∑ |<0 = >0|20B1 C  
where n is the number of bins, which is 10 in this study.  
The c.c. is defined as   
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where n is the number of bins, which is 10 in this study, and <E is  
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2
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and >F is  
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Three-dimensional (3D) and 4D analysis were accomplished using the metrics 
mentioned above and the accuracy of the DVFs from 4D CT and 4D MRI was assessed 
from different perspectives.  
 Figure 7: Relevant quantities illustrated in a figure showing a 4D CT DVF
based, a 4D MRI DVF
2.5.1 3D Analysis 
In 3D analysis, DVFs at each phase were treated as DVFs obtained from 
independent 3D images. Since the magnitude of displacement between the reference 
phase and each non-reference phase varies, it 
discrepancy between ROI 
cine MR is related to the magnitude of displacement. This comparison aimed at 
evaluation of potential susceptibility of the accuracy of the DVF to actual displacement 
magnitude. Considering that displace
the three directions, the single
the reference trajectories 
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DVF-based trajectories. A two tailed Wilcoxon signed-rank test was conducted to 
determine if the expected medians of single-phase difference of 4D CT and 4D MRI were 
different.   
2.5.2 4D Analysis  
In 4D analysis, accuracy of DVFs was evaluated based on the agreement of the 
DVF-based trajectory and the corresponding reference trajectory, measured by the 
trajectory difference and correlation coefficient. Two tailed Wilcoxon signed-rank tests 
were conducted to determine if the expected medians of trajectory difference and 
correlation coefficient of 4D CT and 4D MRI were different.    
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3. Results 
3.1 Patient Selection 
A total of 12 patients were screened for eligibility, seven of which had complete 
image data of 4D CT, 4D MRI and cine MR images, and visible tumors in cine MR 
images. According to the quality of their tumor trajectories from tracking in cine MR 
images, five were rated as eligible. Reasons for the exclusion of the other two are as 
follows.  
The first excluded patient had a tumor too close to the heart. Theoretically, the 
motion of a liver tumor is a superposition of respiratory motion and heart motion. For 
most tumors, the effect from respiratory motion is dominant because the magnitude of 
heart motion is smaller and the already small motion is further mitigated by liver tissues 
between the heart and the tumor. The above statement, however, does not hold for the 
tumor in this patient due to its proximity to the heart. As can be seen from Figure 5, the 
magnitude of high frequency tumor motion caused by heart motion is comparable with 
the magnitude of low frequency tumor motion caused by respiratory motion, making 
identification of respiratory peaks and valleys of the displacement curve extremely 
difficult, if not impossible. Even if respiratory peaks and valleys are located, because the 
heart motion adds considerable fluctuation to the displacement curve, it will not be 
qualified to serve as reference. A satisfactory tumor displacement curve is shown in 
Figure 4 as reference.  
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Figure 8: A tumor displacement curve in the SI direction tracking in the cine 
MR images of a selected patient.  
 
Figure 9: A tumor displacement curve in the SI direction from tracking in the 
cine MR images of the excluded patient with a tumor affected by heart motion.  
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The second patient was excluded because, in the cine MR images, his tumor was 
not moving with respiration, as shown in Figure 3. Since this study aims at evaluating 
accuracy of DVFs from 4D images by comparing the motion information extracted from 
4D images with that information from cine MR images, a stationary tumor that cannot 
provide such information is not eligible for use.  
 
Figure 10: A tumor displacement curve in the SI direction from tracking in the 
cine MR images of the excluded patient with a stationary tumor. 
Table 3: A summary of patient characteristics. The primary site is shown in the 
parentheses if the lesion in the liver is secondary.  
Patient Age (Years) Gender Weight (kg) Primary or Secondary 
1 45 F 61 Secondary (Breast) 
2 67 F 74 Primary 
3 53 M 109 Secondary (Liver) 
4 74 M 102 Secondary (Liver) 
5 67 M 113 Primary 
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3.2 Verification of Agreement between ROI in 4D CT and 4D MR 
Images 
The validity of comparing 4D CT DVF-based and 4D MRI DVF-based tumor 
trajectories with reference tumor trajectories, respectively, relies on the assumption that 
the ROI in 4D CT images and 4D MR images contain the same tissues. The volume of 
ROI in 4D CT and 4D MRI has been guaranteed to be the same by the localization 
method used in this study. It was the position of the center of ROI that required further 
verification. Dright is the distance between the tumor and the right side of body, Dback is 
the distance between the tumor and the back side of body, and Ddia is the distance 
between the tumor and the diaphragm. These three distances were measured in 4D CT 
and 4D MRI and corrected to the distances measured in planning images in the TPS. The 
total percent difference (tot. % diff.) was calculated using the following equation,  
?I?. % ):;;.  |L0MNO,Q$ = L0MNO,#RS|TUV W
|XYZ[,Q$ = XYZ[,#RS|T\R W
|]0Y,Q$ = ]0Y,#RS|TS^  
When the D4D is approximately equal to DTPS, it can be easily demonstrated that 
∆// ` ?I?. % ):;;. 
where ΔV is the volume ROI in 4D images that is not overlapping with the ROI in 
planning images.  
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Table 4: Edge lengths of rectangular ROIs determined in the planning images 
in the TPS.                                                                                                             Unit: mm 
Patient lRL lAP lSI 
1 47.0 45.7 35.0 
2 33.0 29.2 30.0 
3 26.4 39.5 27.0 
4 27.9 24.1 22.5 
5 76.1 94.7 92.6 
 
Table 5: Distance between the center of tumor to the right side of body, the 
posterior side of body, and the diaphragm, measured in the planning images in the 
TPS and in the 4D images at the EOI phase.  
   Distance to Center of Tumor Region (mm)  
Patient Modality  Dright Dback Ddia Tot. % Diff. 
1 
4D CT 
4D 65.6 108.1 67.5 3.00 
TPS 65.7 108.2 66.6 
4D MR 
4D 64.0 100.8 60.0 3.73 
TPS 64.9 101.5 59.9 
2 
4D CT 
4D 81.5 72.7 40.0 2.38 
TPS 81.6 73.2 39.9 
4D MR 
4D 97.0 63.0 35.0 5.93 
TPS 97.4 62.4 35.8 
3 
4D CT 
4D 68.5 161.3 16.5 1.69 
TPS 68.2 161.3 16.4 
4D MR 
4D 62.6 160.8 12.5 6.99 
TPS 63.0 160.1 13.5 
4 
4D CT 
4D 105.3 179.4 59.8 4.01 
TPS 105.7 178.9 59.9 
4D MR 
4D 105.7 171.5 57.3 7.27 
TPS 105.9 171.1 58.4 
5 
4D CT 
4D 90.9 140.7 158.0 1.87 
TPS 91.5 140.7 159.0 
4D MR 
4D 80.5 145.5 168.0 2.62 
TPS 80.7 144.8 166.5 
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It can be observed that the ROI in 4D MR images has uniformly worse degree of 
agreement than ROI in 4D CT. This can be explained by the larger voxel sizes of 4D MR 
images because the largest possible value of |D4D-DTPS| equals half of the voxel length in 
the same direction. Another observation is that ROI with larger edge lengths is less 
susceptible to imperfect alignment. Tot. % Diff. of ROIs in 4D CT and 4D MRI images for 
patient 4, whose tumor is the smallest in edge lengths, are 4.01% and 7.27%, both the 
largest among the five patients whereas Tot. % Diff. of ROIs in 4D CT and 4D MRI 
images for patient 5, who has the largest tumor, are 1.87% and 2.62%, considerably 
lower than average.  
3.3 Comparison of DVF Distribution in Tumor Region for 4D CT 
and 4D MRI 
 
Figure 11: RL displacement vectors between the EOI and the EOE phases in the 
tumor region for all patients. Red boxes are for CT and blue for MRI. The red bars 
stand for the medians. The central 50% of the data points are included in the box. 
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Figure 12: AP displacement vectors between the EOI and the EOE phases in 
the tumor region for all patients. Red boxes are for CT and blue for MRI. The red bars 
stand for the medians. The central 50% of the data points are included in the box. 
 
Figure 13: SI displacement vectors between the EOI and the EOE phases in the 
tumor region for all patients. Red boxes are for CT and blue for MRI. The red bars 
stand for the medians. The central 50% of the data points are included in the box. 
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The range of the magnitude of displacement vector varies considerably from 
patient to patient, noticeably in the RL direction, where the ranges from two patients can 
have no overlapping. The agreement of the ranges of the magnitude of displacement 
vector for 4D CT and 4D MRI is better in the SI direction than in the other two.  
3.4 Reference Tumor Trajectories and DVF-based Tumor 
Trajectories 
3.4.1 Reference Tumor Trajectories 
 
Figure 14: Reference tumor trajectories in the RL direction for all patients. 
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Figure 15: Reference tumor trajectories in the AP direction for all patients. 
 
Figure 16: Reference tumor trajectories in the SI direction for all patients. 
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3.4.2 DVF-based Tumor Trajectories 
 
Figure 17: 4D CT DVF-based tumor trajectories in the RL direction for all 
patients.  
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Figure 18: 4D CT DVF-based tumor trajectories in the AP direction for all 
patients.  
 
Figure 19: 4D CT DVF-based tumor trajectories in the SI direction for all 
patients.  
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Figure 20: 4D MRI DVF-based tumor trajectories in the RL direction for all 
patients. 
 
Figure 21: 4D MRI DVF-based tumor trajectories in the AP direction for all 
patients. 
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Figure 22: 4D MRI DVF-based tumor trajectories in the SI direction for all 
patients. 
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 3.4 Evaluation of DVFs from 4D CT and 4D MRI
3.4.1 3D Analysis  
3.4.1.1 Single-phase Difference
Figure 23: The single
plotted against the tumor displacement in the SI direction. Data from all 
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 vs. Magnitude of Displacement 
-phase difference for 4D CT (top) and 4D 
patients are reflected in this figure.  
 
 
MRI (bottom) is 
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According to the results of linear regression, the single-phase difference for 4D 
MRI shows a greater correlation with the magnitude of displacement than the single-
phase difference for 4D CT because the slope of the regressed line for 4D MRI is -0.42, 
larger than the slope for 4D CT (-0.37) in terms of the absolute value. That being said, the 
coefficients of determination for both regressed line are not large, meaning that a single-
phase difference can fall at somewhere quite distant from the value predicted by the 
regressed line. The linear dependence of the single-phase difference on the displacement 
is not conclusive for neither 4D CT nor 4D MRI. It is interesting to see that, although the 
regression result indicates a weaker dependence on displacement and a more scattered 
distribution with respect to the regressed line, the single-phase difference for 4D CT are 
uniformly below zero except for one point. Considering the regulation term in a DIR 
algorithm, which is intended to eliminate drastic change in the DVF, has a smoothing 
effect on the DVF, it is expected that the deformation vectors with large magnitudes are 
more susceptible to this effect and therefore tend to be smaller than actual 
displacements.  
3.4.2.2 Statistical Study on the Absolute Single-phase Difference  
A Wilcoxon signed-rank test was accomplished on the absolute single-phase 
difference in millimeter and in number of voxels for all the three directions to test if the 
median of X-Y equals zero, where X stands for the absolute single-phase difference for 
4D CT combining the ten phases in all the five patients together, and Y stands for the 
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absolute single-phase difference for 4D MRI combining the ten phases in all the five 
patients together. In this test, the difference between the DVF-based tumor trajectories 
and the corresponding reference trajectory at each phase is treated equally, rather than 
averaged for each patient. The validity relies on the assumption that the single-phase 
difference does not depend on any patient-specific characteristics.  
Table 6: P-values of a Wilcoxon signed-rank test on the absolute ph. diff. in 
mm, and in number of voxels for the RL, the AP, and the SI directions. 
 RL AP SI 
absolute ph. diff. (mm) 0.0093 0.0011 0.8170 
absolute ph. diff. (voxels) <5E-5 <2E-6 <2E-4 
 
All p-values in Table. 6 reach the significant level of 0.05 except for the p-value 
for the test on the absolute single-phase difference in millimeters in the SI direction, 
suggesting that the median of the absolute single-phase difference in millimeters in the 
RL and the AP directions, and the single-phase difference in voxels in the RL, the AP, 
and the SI directions are likely to be different for 4D CT and 4D MRI. By comparing the 
trajectory difference in millimeters, and in number of voxels, as shown in Table. 7, which 
are also the mean values of the absolute single-phase differences in millimeters and in 
voxels, the results of the signed-rank tests are in favor of the hypotheses that accuracy of 
the 4D MRI DVF is potentially superior to the accuracy of the 4D CT DVF except for the 
SI direction when evaluated in length.   
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3.4.2 4D Analysis 
3.4.2.1 Quantitative Results for All Patients 
Table 7: Results of agreement measurement between DVF-based trajectories 
and trajectories from tracking in cine MR images in the RL, AP and SI directions.  
Patient Metric Modality RL AP SI 
1 
traj. diff. (mm) 
4D CT 0.54 0.90 2.72 
4D MR 0.48 0.36 0.57 
traj. diff. (voxels) 
4D CT 0.43 0.71 1.09 
4D MR 0.26 0.19 0.11 
c. c. 
4D CT 0.06 0.90 0.74 
4D MR 0.08 0.94 0.97 
2 
traj. diff. (mm) 
4D CT 0.67 1.00 1.01 
4D MR 0.42 0.43 3.56 
traj. diff. (voxels) 
4D CT 0.52 0.79 0.40 
4D MR 0.30 0.31 0.71 
c. c. 
4D CT 0.04 0.26 0.97 
4D MR 0.68 0.30 0.86 
3 
traj. diff. (mm) 
4D CT 0.52 1.02 1.78 
4D MR 0.45 1.24 1.45 
traj. diff. (voxels) 
4D CT 0.38 0.74 0.89 
4D MR 0.24 0.66 0.29 
c. c. 
4D CT 0.92 0.92 0.85 
4D MR 0.92 0.54 0.85 
4 
traj. diff. (mm) 
4D CT 4.01 1.98 3.13 
4D MR 3.55 1.22 4.36 
traj. diff. (voxels) 
4D CT 3.16 1.56 1.25 
4D MR 1.89 0.65 0.87 
c. c. 
4D CT -0.92 0.81 0.94 
4D MR 0.48 0.96 0.98 
5 
traj. diff. (mm) 
4D CT 0.76 2.45 1.81 
4D MR 0.54 2.30 1.22 
traj. diff. (voxels) 
4D CT 0.60 1.93 0.72 
4D MR 0.29 1.22 0.24 
c. c. 
4D CT 0.66 0.96 0.97 
4D MR 0.80 0.84 0.97 
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Table 8: Averaged traj. diff. in mm, traj. diff. in number of voxles and 
correlation coefficients for the five patients. 
Metric Modality RL AP SI 
traj. diff. (mm) 
4D CT 1.30±1.36 1.47±0.63 2.09±0.75 
4D MR 1.09±1.23 1.11±0.70 2.23±1.46 
traj. diff. (voxels) 
4D CT 1.02±1.07 1.15±0.50 0.87±0.29 
4D MR 0.60±0.65 0.61±0.36 0.45±0.29 
c. c. 
4D CT 0.15±0.64 0.77±0.26 0.89±0.09 
4D MR 0.59±0.30 0.72±0.26 0.93±0.06 
 
This study aims at evaluating the accuracy of DVFs from 4D CT and 4D MRI by 
comparing similarity between the DVF-based tumor trajectories and the tumor 
trajectories from tracking in cine MR images. The similarity is quantified using trajectory 
difference and correlation coefficient.  
Table 8 shows the trajectory differences, and correlation coefficients averaged 
over the five patients. The trajectory differences in millimeters for both 4D CT and 4D 
MRI increase as the direction goes from RL, AP to SI. Since typically the respiratory 
motion has the largest amplitude in the SI direction, less in the AP direction and the 
smallest in the RL direction, the increase in trajectory difference agrees with the 
observation that the larger difference between the primary and the secondary images, 
the larger the deformation error.  
As for the correlation coefficient, an increasing trend is observed for both 4D CT 
and 4D MRI as the direction for which correlation coefficient is calculated varies from 
RL, AP to SI. Meaning that the trends of the reference trajectories and DVF-based 
 45 
trajectories match best in the SI direction, less good in the AP direction and worst in the 
RL direction. It is worth noting that curves with good correlation may still have large 
difference.  
Although the metrics show consistent results as the direction varies, they fail to 
indicate which modality is better. All metrics did not give consistent indications of 
which modality can provide more accurate DVFs. In the SI direction, 4D CT trajectories 
exhibited smaller trajectory difference in millimeters (traj. diff. (mm)= 2.09±0.75mm) but 
larger trajectory difference in voxels (traj. diff. (voxels)= 0.87±0.29) and smaller 
correlation coefficient (c. c. = 0.89±0.09) than 4D MR trajectories (traj. diff. (mm)= 
2.23±1.46mm, traj. diff. (voxels)= 0.45±0.29, c. c. = 0.93±0.06) whereas 4D MR (traj. diff. 
(mm)= 1.09±1.23mm, traj. diff. (voxels)= 0.60±0.65, c. c. = 0.59±0.30) surpassed 4D CT (traj. 
diff. (mm)= 1.30±1.36mm, traj. diff. (voxels)= 1.02±1.07, c. c. = 0.15±0.64) in every metric 
in the RL direction. In the AP direction, 4D MR trajectories have a smaller trajectory 
difference in millimeters (traj. diff. (mm) = 1.11±0.70mm) and a smaller trajectory 
difference in voxels (traj. diff. (voxels) = 0.61±0.36) but a slightly smaller correlation 
coefficient (c. c. = 0.72±0.26) than 4D CT trajectories (traj. diff. (mm) = 1.47±0.63mm, traj. 
diff. (voxels) = 1.15±0.50, c. c. = 0.77±0.26). This inconsistency indicates that, by using 4D 
analysis, for the five patients studied, no evidence shows that DVFs from 4D CT are 
more accurate than DVFs from 4D MRI or vice versa.  
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Although no definite conclusion can be made in terms of the accuracy of 4D CT 
and 4D MRI from the patient-averaged results shown in Table 8, patient-specific results 
in Table 7 show an interesting results that, for patient 1, accuracy of DVFs from 4D MRI 
is dominantly better than that of DVFs from 4D CT.  
3.4.2.2 Statistical Study on the Trajectory Difference and the Correlation Coefficient 
A Wilcoxon signed-rank test was conducted to test if the median of X-Y equals 
zero, where X stands for the trajectory difference in millimeters for 4D CT for each 
patient, and Y stands for the trajectory difference in millimeters for 4D MRI for each 
patient. The same test was also conducted for the trajectory differences in number of 
voxels for 4D CT and 4D MRI, and for the correlation coefficients for 4D CT and 4D MRI. 
The p-values are summarized in Table. 9.  
Table 9: P-values of a Wilcoxon signed-rank test on traj. diff. in mm, traj. diff. 
in voxels, and c. c for the RL, the AP, and the SI directions. 
 RL AP SI 
traj. diff. (mm) 0.0625 0.1875 1.0000 
traj. diff. (voxels) 0.0625 0.0625 0.1250 
c. c. 0.1250 0.1250 1.0000 
 
No p-value is below the significant level of 0.05 in Table. 9, meaning that the 
hypotheses that the median of X-Y equals zero cannot be rejected. Therefore, the results 
of the trajectory difference in millimeters, the trajectory difference in number of voxels, 
and the correlation coefficient do not support that the accuracy of 4D CT DVF is 
significantly different from the accuracy of 4D MRI DVF.  
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4. Discussion 
4.1 Interpretation 
4.1.1 DVF Distribution 
It was expected that the variation of the magnitude of displacement vectors 
inside the ROI was relatively small considering that the DVF was smoothed during 
registration. The magnitude distribution of the DVF for some patients, however, covers 
a wide range. The overlapping between the ranges of the magnitude of displacement 
vectors from 4D CT and 4D MRI varies considerably with the patient. No clear trend in 
terms of the pattern and the degree of overlapping has been observed. It should also be 
noted that a good agreement in magnitude distribution cannot be used as evidence of 
good agreement between two DVFs. Spatial distributions must be compared before two 
DVFs can be considered in agreement with each other. In sum, the lack of similarity 
between the DVFs from 4D CT and 4D MRI may necessitate patient-by-patient 
examination of the accuracy of 4D CT and 4D MRI DVF if the DVF is to be applied for 
research and clinical use.  
4.1.2 Trajectory Differences in Length and in Number of Voxels 
As shown in Table. 8, the trajectory difference in millimeters for 4D CT is greater 
than that for 4D MRI in the RL and the AP directions whereas the trajectory difference in 
millimeters for 4D CT is smaller in the SI direction. The statistical results do not support 
there is significant difference between the median of the trajectory difference in 
 48 
millimeters for 4D CT and 4D MRI. Therefore, the accuracy of the DVFs from 4D CT and 
4D MRI is concluded as comparable with current results. However, if the discrepancy 
between the DVF-based trajectories and the reference trajectories is measured in number 
of voxels, the DVF from 4D MRI performs better in all the three directions.  
4D MR images have better soft-tissue contrast and more features, which should 
lead to improved registration accuracy. The comparable results shown in this study 
suggest that the benefit brought by high soft-tissue contrast is nullified by other factors. 
It is hypothesized that registration errors are also related to resolution and it is the 
inferior resolution of 4D MRI compared to that of 4D CT that results in the comparable 
accuracy of DVFs from 4D CT and 4D MRI. This statement is supported by the data 
showing that 4D MRI has smaller single-phase differences and trajectory differences in 
number of voxels. This hypothesis is subject to further investigation and possible 
approaches are proposed in 4.3 Future Work.  
From the voxel-based perspective, the DVFs from 4D MRI show more accuracy 
in terms of trajectory difference. From the perspective of application, however, similar 
results in trajectory difference of 4D CT and 4D MR indicates the magnitude of possible 
error that may be introduced to calculation based on the DVF are likely to be the same.  
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4.2 Limitations 
4.2.1 Limited Number of Patients 
The major limitation of this study is the small number of patients, which is 
partially because the small number of patients that have taken 4D MR images and the 
suboptimal image quality. The low contrast of tumor and thus the low visibility in cine 
MR images result in the exclusion of a patient.  
This inadequacy may leave potential statistically significant conclusions 
uncovered. The paired t-test, which is capable of yielding stronger conclusion than the 
two-tailed Wilcoxon signed-rank test, requires the data set to be normal distributed, 
which need to be tested first. This normality test is difficult for a data set of only five 
samples. Although not assuming normal distribution of data sets, the two-tailed 
Wilcoxon signed-rank test requires at least six pairs of data points to arrive at any 
statistically significant conclusion.  
Under the assumption that the accuracy of the DVF does not depend on patient-
specific characteristics, single-phase differences from all the five patients are analyzed as 
a whole, arriving at some statistically significant results. It should be noted that the 
validity of the assumption may be affected by different breathing patterns, different 
voxel sizes, etc.  
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4.2.2 Temporal Dependence of Patient’s Breathing Patterns 
An underlying assumption of this study is that patients have constantly regular 
breathing pattern independent of time, meaning information of ROI motion recorded in 
4D CT, 4D MRI and cine MR images is identical. This assumption is, however, not 
exactly true. For some of the patients, they could maintain a relatively regular breathing 
period and amplitude, though small variation in period and amplitude can still be 
observed. For the other patients, apparent change in breathing period and amplitude 
were observed either in images of a single modality or between images of different 
modalities. This drift of baseline may contribute to the difference between DVF-based 
trajectories and the reference trajectories, complicating the evaluation of DIR accuracy. 
Breathing training is a possibly approach to reducing the variation of a patient’s 
breathing pattern and should be considered as part of the protocol in future prospective 
studies.  
4.3 Future work 
A major limitation of this study is the small number of patients, making the 
discovery of potential statistically significant results extremely difficult. Despite the 
limited size of data, some trends are still observed and needed to be confirmed by a 
sample large enough for statistical analysis. Considering that an eligible patient for this 
study must have 4D CT, 4D MRI, and cine MR images at the same time, accruing 
sufficient number of eligible patients may take a fairly long time. I would suggest taking 
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orthogonal cine MR images at anatomical landmarks in addition to tumors in the liver. If 
the landmarks can be contoured on CT and MR images for the purpose of localization, 
these landmarks can be used as, to some extent, independent targets for evaluation of 
the accuracy of DVF. By doing so, the number of samples can be increased at a faster 
rate than the number of accrued patients.  
There is also room for improvement of the strength of conclusion if the 
resolution of 4D MR images can be boosted to the same level as 4D CT images. As 
presented above, when measured in number of voxels, the results suggest that the 
accuracy of 4D MRI DVF may be higher than that of 4D CT DVF. Currently, the 
resolution of 4D MR images is mainly limited in the slice thickness. The 4D MR images 
used in this study were all acquired in the axial view. As a consequence, the large slice 
thickness in the SI direction, in which the respiratory motion is dominant, may 
undermine the accuracy of DIR. In the future, the 4D MR images can be acquired in the 
sagittal or coronal view such that the possible effect of coarse resolution on the accuracy 
of DIR can be excluded and more decisive results and conclusion are expected. In 
addition, the 4D MR images can be interpolated and re-sliced such that the 4D MR 
images have the same voxel size with the 4D CT images. A study comparing the DIR 
results from interpolated 4D MR images with those from original 4D MR images can be 
conducted to investigate whether DIR algorithms interpolate the input images.  
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It is also desirable to repeat the study using different DIR algorithms, 
considering that the accuracy of DVFs obtained from different algorithms varies 
significantly. Although for most commercially available DIR software, the registration 
process is more like a black box with no customizable parameters, DIR algorithms in 
open-source toolkits tend to provide flexibility of parameter optimization, which may 
considerably affect the accuracy of the DVF.40 Therefore, the study should be repeated 
using more algorithms, including those allowing for parameter optimization.  
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5. Conclusion 
We have implemented a novel approach for evaluating accuracy of DVFs based 
on 4D imaging for studying liver deformation using cine MR images as reference. 
Considerable variation in the distribution of the magnitude of deformation vectors in the 
ROIs encompassing tumors were observed between 4D CT DVF and 4D MR DVF, 
necessitating careful evaluation of the accuracy of the DVF before application of the DVF 
for research and clinical use. The discrepancy between the DVF and reference 
respiratory motion has been discovered to be moderately influenced by the magnitude 
of respiratory motion. Current results from patient-wise study suggest that DVFs from 
4D CT and 4D MRI are comparable. Although not supported by statistically significant 
results, a trend that, if measured in number of voxels, the discrepancy in the motion of 
ROI between 4D MRI and cine MR imaging is smaller than that between 4D CT and cine 
MR imaging has been observed. When the registration for each two phases is considered 
as independent of patient-specific characteristics, 4D MRI shows possibly better DVF 
accuracy than 4D CT, when measured in number of voxels.   
Further studies involving a sufficient number of patients for statistical analysis 
and using 4D MR images with resolution comparable with resolution of 4D CT images 
are warranted and expected to determine whether there is significant difference between 
the accuracy of 4D CT and 4D MRI DVFs and to confirm whether improved resolution 
of 4D MRI images can increase the accuracy of 4D MRI DVF.  
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